stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / JNJ / Revenue

Johnson & Johnson Revenue 2007–2025

Johnson & Johnson (JNJ) annual revenue by fiscal year, computed from SEC filings.

Fiscal yearRevenueChange (YoY)
FY 2025$94.19B+6.0%
FY 2024$88.82B+4.3%
FY 2023$85.16B-10.3%
FY 2022$94.94B+20.6%
FY 2022$78.74B-4.7%
FY 2021$82.58B+0.6%
FY 2019$82.06B+0.6%
FY 2018$81.58B+6.7%
FY 2017$76.45B+6.3%
FY 2017$71.89B
FY 2016$0
FY 2014$0
FY 2013$0
FY 2012$0
FY 2012$0
FY 2011$0
FY 2010$0
FY 2008$0
FY 2007$0

Source: Johnson & Johnson SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Johnson & Johnson

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Johnson & Johnson — frequently asked questions

What is Johnson & Johnson's revenue?

Johnson & Johnson (JNJ) reported revenue of $94.19B for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from Johnson & Johnson's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More JNJ financial history

Full JNJ fundamentals page → · All 1,500+ companies →